✦ LIBER ✦

Once-weekly enteric-coated fluoxetine is effective in the long-term treatment of depression,

Book ID: 120870360
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012400-00031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once weekly fluconazole is effective in

Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study

✍ A.K. Gupta; N. Dlova; P. Taborda; N. Morar; V. Taborda; C.W. Lynde; N. Konnikov; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Hypnotherapy is effective in the long-te

Hypnotherapy is effective in the long-term treatment of functional dyspepsia

✍ Emma L. Calvert; Lesley A. Houghton; Patricia Cooper; Peter J. Whorwell 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 179 KB

The efficacy of long-term psychodynamic

The efficacy of long-term psychodynamic psychotherapy, fluoxetine and their combination in the outpatient treatment of depression

✍ Bastos, Andre Goettems; Guimaraes, Luciano Santos Pinto; Trentini, Clarissa Marc 📂 Article 📅 2014 🏛 Taylor and Francis Group 🌐 English ⚖ 299 KB

Effect of long-term fluoxetine treatment

Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells

✍ Ruth Iceta; José E. Mesonero; Ana I. Alcalde 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 473 KB

955 – Long-term effectiveness of long- a

955 – Long-term effectiveness of long- and short-term psychotherapy in the treatment of depressive and anxiety disorders

✍ Knekt, P.; Jääskeläinen, T.; Virtala, E.; Härkänen, T.; Laaksonen, M.; Lindfors, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 29 KB

Quetiapine is effective against anxiety

Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia

✍ Siegfried Kasper 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

This analysis of data from the open-label extension (OLE) phases of three randomized clinical trials of quetiapine in patients with schizophrenia (n=415) was undertaken to investigate whether the initial improvements in anxiety and depressive symptoms were maintained during long-term treatment. The